These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

265 related items for PubMed ID: 20960417

  • 1. Effects of topical 0.5% levobunolol alone or in association with 2% dorzolamide compared with a fixed combination of 0.5% timolol and 2% dorzolamide on intraocular pressure and heart rate in dogs without glaucoma.
    Scardillo A, Pugliese M, De Majo M, Niutta PP, Pugliese A.
    Vet Ther; 2010; 11(3):E1-6. PubMed ID: 20960417
    [Abstract] [Full Text] [Related]

  • 2. Comparison of effects of topical levobunolol to a combination of timolol-dorzolamide on intraocular pressure and pulse rate of healthy dogs.
    Pugliese M, Scardillo A, Niutta PP, Pugliese A.
    Vet Res Commun; 2009 Sep; 33 Suppl 1():205-7. PubMed ID: 19626454
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. [Ocular pulse amplitude, intraocular pressure and beta blocker/carbonic anhydrase inhibition in combined therapy of primary open-angle glaucoma].
    Schmidt KG, von Rückmann A, Becker R, Pillunat LE.
    Klin Monbl Augenheilkd; 1999 Dec; 215(6):361-6. PubMed ID: 10637801
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. The efficacy and safety of the dorzolamide-timolol combination versus the concomitant administration of its components.
    Strohmaier K, Snyder E, DuBiner H, Adamsons I.
    Ophthalmology; 1999 Dec; 106(12 Suppl):1-9. PubMed ID: 10598691
    [Abstract] [Full Text] [Related]

  • 7. Experience with Cosopt, the fixed combination of timolol and dorzolamide, after switch from free combination of timolol and dorzolamide, in Swiss ophthalmologists' offices.
    Gugleta K, Orgül S, Flammer J.
    Curr Med Res Opin; 2003 Dec; 19(4):330-5. PubMed ID: 12841926
    [Abstract] [Full Text] [Related]

  • 8. [Comparative study of the pressure lowering efficacy and variations in the ocular pulse amplitude between fixed combinations of dorzolamide/timolol and brinzolamide/timolol].
    Sánchez-Pulgarín M, Martínez-de-la-Casa JM, García-Feijoó J, Sáenz-Francés F, Santos-Bueso E, Herrero-Vanrell R, García Sánchez J.
    Arch Soc Esp Oftalmol; 2011 May; 86(5):149-53. PubMed ID: 21624655
    [Abstract] [Full Text] [Related]

  • 9. Experience with COSOPT, the fixed combination of timolol and dorzolamide, gained in Swiss ophthalmologists' offices.
    Pajic B, Conductors of the Swiss COSOPT Survey (CSCS).
    Curr Med Res Opin; 2003 May; 19(2):95-101. PubMed ID: 12740152
    [Abstract] [Full Text] [Related]

  • 10. A randomized trial in patients inadequately controlled with timolol alone comparing the dorzolamide-timolol combination to monotherapy with timolol or dorzolamide.
    Clineschmidt CM, Williams RD, Snyder E, Adamsons IA.
    Ophthalmology; 1999 Dec; 106(12 Suppl):17-24. PubMed ID: 10598693
    [Abstract] [Full Text] [Related]

  • 11. [Innovative glaucoma therapy. Glaucoma therapy with topical carbonic anhydrase inhibitors].
    Herkel U, Pfeiffer N.
    Ophthalmologe; 2001 Oct; 98(10):929-33. PubMed ID: 11699313
    [Abstract] [Full Text] [Related]

  • 12. Comparing the fixed combination dorzolamide-timolol (Cosopt) to concomitant administration of 2% dorzolamide (Trusopt) and 0.5% timolol -- a randomized controlled trial and a replacement study.
    Francis BA, Du LT, Berke S, Ehrenhaus M, Minckler DS, Cosopt Study Group.
    J Clin Pharm Ther; 2004 Aug; 29(4):375-80. PubMed ID: 15271105
    [Abstract] [Full Text] [Related]

  • 13. The preclinical pharmacology of dorzolamide hydrochloride, a topical carbonic anhydrase inhibitor.
    Sugrue MF.
    J Ocul Pharmacol Ther; 1996 Aug; 12(3):363-76. PubMed ID: 8875343
    [Abstract] [Full Text] [Related]

  • 14. Effects of topical 2% dorzolamide hydrochloride alone and in combination with 0.5% timolol maleate on intraocular pressure in normal feline eyes.
    Dietrich UM, Chandler MJ, Cooper T, Vidyashankar A, Chen G.
    Vet Ophthalmol; 2007 Aug; 10 Suppl 1():95-100. PubMed ID: 17973840
    [Abstract] [Full Text] [Related]

  • 15. Changes in intraocular pressure associated with topical dorzolamide and oral methazolamide in glaucomatous dogs.
    Gelatt KN, MacKay EO.
    Vet Ophthalmol; 2001 Mar; 4(1):61-7. PubMed ID: 11397321
    [Abstract] [Full Text] [Related]

  • 16. Dorzolamide-timolol combination versus concomitant administration of its components.
    Odberg T.
    Ophthalmology; 1999 Jun; 106(6):1044-5. PubMed ID: 10366067
    [No Abstract] [Full Text] [Related]

  • 17. Effect of topical administration of 2% dorzlamide hydrochloride or 2% dorzlamide hydrochloride-0.5% timolol maleate on intraocular pressure in clinically normal horses.
    Willis AM, Robbin TE, Hoshaw-Woodard S, Wilkie DA, Schmall ML.
    Am J Vet Res; 2001 May; 62(5):709-13. PubMed ID: 11341390
    [Abstract] [Full Text] [Related]

  • 18. Topical carbonic anhydrase inhibitors and visual function in glaucoma and ocular hypertension.
    Gugleta K.
    Curr Med Res Opin; 2010 Jun; 26(6):1255-67. PubMed ID: 20350146
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Three-month, randomized, parallel-group comparison of brimonidine-timolol versus dorzolamide-timolol fixed-combination therapy.
    Nixon DR, Yan DB, Chartrand JP, Piemontesi RL, Simonyi S, Hollander DA.
    Curr Med Res Opin; 2009 Jul; 25(7):1645-53. PubMed ID: 19476406
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.